medigraphic.com
ISSN 1029-3043 (Electronic)

2013, Number 1

<< Back Next >>

Medicentro 2013; 17 (1)

Estudio histomorfométrico del núcleo celular del carcinoma papilar de tiroides

López PR, García GM, Pérez PN, López PG

Language: Spanish
References: 17
Page: 9-16
PDF size: 187.72 Kb.


ABSTRACT

A morphometric evaluation of thyroid papillary carcinoma was carried out, with the objective of identifying possible morphometric parameters that contribute to precise its histological diagnosis. A number of 32 diagnosed biopsies of the University Hospital “Celestino Hernández Robau”, from Santa Clara were studied. Nuclear morphometric variables were determined, such as, area, perimeter, range and shape factor, by means of COMSDI PLUS version 1.0 computing program. Papillary carcinoma in its non classical histological variants (follicular, oxyphilic and diffuse sclerosing) showed more elevated values in area, perimeter and nuclear range, while, papillary carcinoma, in its classical variant, showed a high value in shape factor. The correlation study between studied variables did not showed similarity in its results in both histological variants.


REFERENCES

  1. Maitra A, Abbas AK. El sistema endocrino. En: Kumar V, Abbas A, Fausto N. Robbins y Cotran Patología estructural y funcional. 7ma ed. Madrid: Elsevier; 2005. p.1159-230.

  2. Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, et al. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol [Internet]. 2011 Jun. [citado 30 ene. 2013];22(2):[aprox. 10 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21509594

  3. Cañadas Garre M, López de la Torre Casares M, Becerra Massare P, López Nevot MA, Villar Del Moral J, Muñoz Pérez N, et al. BRAF(T1799A) Mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma. Endocrinol Nutr [Internet]. 2011 Apr. [citado 30 ene. 2013];58(4):[aprox. 7 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21441079

  4. Ministerio de Salud Pública, Instituto Nacional de Oncología y Radiobiología. Registro Nacional del Cáncer. La Habana: MINSAP; 2009.

  5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71-96.

  6. Romei C, Elisei R. RET/PTC Translocations and clinic-pathological features in human papillary thyroid carcinoma. Front Endocrinol (Lausanne) [Internet]. 2012 [citado 30 ene. 2013];3:[aprox. 8 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356050/

  7. Kandil E, Khalek MA, Ibrahim WG, Alabbas H, Yau L, Firedlander P, et al. Papillary thyroid carcinoma in black thyroids. Head Neck [Internet]. 2011 Dec. [citado 30 ene. 2013];33(12):[aprox. 3 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/21416546

  8. Finley DJ, Zhu B, Barden CB, Fahey TJ. Discrimination of benign and malignant thyroid nodules by molecular profiling. An Surg. 2004;240:425-36.

  9. Ustun H, Atalay FO, Ekinci C. Adenoid cystic variant of papillary thyroid carcinoma: a case report with fine-needle aspiration cytology. Diagn Cytopathol. 2008;36(1):64-6.

  10. Bruins NA, Oswald JE, Morreau H, Kievit J, Pavel S, Smelt AH. Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline. Neth J Med. 2007;65:185-7.

  11. Comparative morphometric analysis of thyroid in invasive part and intranodular part of tumor in minimally invasive follicular carcinoma of thyroid. Nobel Medicus J [Internet]. 2010 Sep.-Dic. [citado 30 ene. 2013];6(3):[aprox. 4 p.]. Disponible en: http://www.nobelmedicus.com/contents/201063/24-27.htm

  12. Kirillov VA, Yuschenko YP, Papleuka AA, Demidchik EP. Thyroid carcinoma diagnosis based on a karyometric parameters of follicular cells. Cancer [Internet]. 2001 Oct. 1 [citado 10 mayo 2008];92(7):[aprox. 10 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/11745254

  13. Tseleni- Belafouta S, Paraskevakou H, Damaris P. Computerized morphometric study on fine needle aspirates of cellular follicular lesions of the thyroid. Anal Quant Cytol Histol [Internet]. 2000 Aug. [citado 11 mayo 2008];22(4):[aprox. 4 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/10965408

  14. Andersen L, Kayser L, Keiding N, Thomson J. A morphometric analysis of nucleoli in cultured carcinoma cells of the human thyroid. Anal Cell Pathol [Internet]. 1998 [citado 11 mayo 2008];16(3):[aprox. 10 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9699942

  15. Sobrinho-Simoes M, Sambade C, Fonseca E, Soares P. Poorly differentiated carcinomas of the thyroid gland: a review of the clinic-pathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol [Internet]. 2002 Apr. [citado 11 mayo 2008];10(2):[aprox. 9 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12075405

  16. Baloch ZW, Segal JP, LiVolsi VA. Unique growth pattern in papillary carcinoma of the thyroid gland mimicking adenoid cystic carcinoma. Endocr Pathol [Internet]. 2011 Dec. [citado 30 ene. 2013];22(4):[aprox. 3 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Unique+growth+pattern+in+papillary+carcinoma+of +the+thyroid+gland+mimicking+adenoid+cystic+carcinoma

  17. Shibru D, Chung KW, Kebebew E. Recent developments in the clinical application of thyroid cancer biomarkers. Current Opinion Oncol. 2008;20:13-8.




2020     |     www.medigraphic.com